Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1

Cited by (825)

Items 501–600 of 825

  1. Advances in colorectal cancer genomics and transcriptomics drive early detection and prevention
    Kuen Kuen Lam, Lai Fun Thean, Peh Yean Cheah · 2021 · The International Journal of Biochemistry & Cell Biology
  2. Immunoprofiles and DNA Methylation of Inflammatory Marker Genes in Ulcerative Colitis-Associated Colorectal Tumorigenesis
    Satu Mäki‐Nevala, Sanjeevi Ukwattage, Erkki‐Ville Wirta, Maarit Ahtiainen, Ari P. Ristimaki, Toni T. Seppälä, Anna Lepistö, Jukka‐Pekka Mecklin, Païvi Peltomäki · 2021 · Biomolecules
  3. Molecular Approach to Colorectal Carcinoma
    Cameron M. Beech, Jaclyn Frances Hechtman · 2024 · Clinics in Laboratory Medicine
  4. HNPCC-Associated Pheochromocytoma
    Brian P. Riff, Bryson W. Katona, Myra L. Wilkerson, Katherine L. Nathanson, David C. Metz · 2015 · Pancreas
  5. Hereditary colorectal cancer syndromes
    Sabela Carballal, María Liz Leoz, Leticia Moreira, Teresa Ocaña, Francesc Balaguer · 2014 · Colorectal Cancer
  6. Identification of allelic expression imbalance genes in human hepatocellular carcinoma through massively parallel DNA and RNA sequencing
    Qiudao Wang, Yan An, Qing Yuan, Qi Yao, Ying Ou, Junhui Chen, Jian Jun Huang · 2016 · Medical Oncology
  7. Microsatellite Instability and its Significance to Hereditary and Sporadic Cancer
    Jeffery W. Bacher, Linda J. Clipson, Leta S. Steffen, Richard B. Halberg · 2016 · InTech eBooks
  8. Primary intramucosal synovial sarcoma of the sigmoid colon in a patient with a germline mutation in the MSH2 gene: A case report
    Yasuyuki Shigematsu, Kyoko Yamashita, Manabu Takamatsu, Taisuke Tanizawa, Yuki Togashi, Takeshi Nakajima, Akiko Chino, Hiroshi Kawachi, Kengo Takeuchi · 2020 · Pathology International
  9. Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers
    Ellis L. Eikenboom, Helena C. van Doorn, Winand N.M. Dinjens, Hendrikus Jan Dubbink, Willemina R.R. Geurts-Giele, Manon C.W. Spaander, Carli M.J. Tops, Anja Wagner, Anne Goverde · 2021 · Cancers
  10. DNA Mismatch Repair Gene Variant Classification: Evaluating the Utility of Somatic Mutations and Mismatch Repair Deficient Colonic Crypts and Endometrial Glands
    Romy Walker, Khalid Mahmood, Julia Como, Mark Clendenning, Jihoon Eric Joo, Peter Georgeson, Sharelle L. Joseland, Susan Preston, Bernard J. Pope, James M. K. Chan et al. · 2023 · Cancers
  11. Pan-cancer prevalence, risk, and clinical and demographic characteristics of Lynch Syndrome-associated variants in BioBank Japan
    Keijiro Mizukami, Yoshiaki Usui, Yusuke Iwasaki, Kouya Shiraishi, Makoto Hirata, Yoichiro Kamatani, Mikiko Endo, Satoshi Takahashi, Yoshiki Mochizuki, Mitusyo Yamaguchi et al. · 2025 · Communications Medicine
  12. Evaluation of Classic, Attenuated, and Oligopolyposis of the Colon
    Jessica M. Long, Jacquelyn M. Powers, Bryson W. Katona · 2021 · Gastrointestinal Endoscopy Clinics of North America
  13. Survival of Patients with Resected Microsatellite Instability-High, Mismatch Repair Deficient, and Lynch Syndrome-Associated Pancreatic Ductal Adenocarcinomas
    Ellis L. Eikenboom, Naaz F. Nasar, Kenneth Seier, Mithat Gönen, Manon C.W. Spaander, Eileen Mary O'Reilly, William R. Jarnagin, Jeffrey A. Drebin, Michael Ian D'Angelica, T. Peter Kingham et al. · 2024 · Annals of Surgical Oncology
  14. A frameshift mutation in exon 19 of MLH1 in a Chinese Lynch syndrome family: a pedigree study
    Qiaoqi Sui, Jiang Wu, X. Wu, Yihong Ling, Zhi-Zhong Pan, Pei-Rong Ding · 2019 · Journal of Zhejiang University SCIENCE B
  15. The nonsense mutation MSH2 c.2152C>T shows a founder effect in Portuguese Lynch syndrome families
    Manuela Pinheiro, Inês Francisco, Carla Pinto, Ana Peixoto, Isabel Veiga, Bruno Filipe, Catarina Santos, Sofia Maia, João Silva, Pedro Pinto et al. · 2019 · Genes Chromosomes and Cancer
  16. RIP140 regulates POLK gene expression and the response to alkylating drugs in colon cancer cells
    Pascale Palassin, Marion Lapierre, Sandrine Bonnet, Marie‐Jeanne Pillaire, Balázs Győrffy, Catherine Teyssier, Stéphan Jalaguier, Jean‐Sébastien Hoffmann, Vincent Cavaillès, Audrey Castet‐Nicolas · 2022 · Cancer Drug Resistance
  17. Molecular Targeted Therapy in Oncology Focusing on DNA Repair Mechanisms
    Carlos Garzón-Hernández, Natalia Ramírez-Merino, Maria Cruz Martin Soberón · 2022 · Archives of Medical Research
  18. The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer
    Bangwei Fang, Wei Yu, Jian Gang Pan, Tingwei Zhang, Dingwei Ye, Yao Zhu · 2023 · Journal of Clinical Medicine
  19. A robust microsatellite instability detection model for unpaired colorectal cancer tissue samples
    Zili Zhang, Hua Wan, Bing Hong XU, Hongyang He, Guangyu Shan, Jingbo Zhang, Qixi Wu, Tong Li · 2023 · Chinese Medical Journal
  20. Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity
    Nicoletta Staropoli, Angela Salvino, Federica Falcone, Valentina Farenza, Martina Costa, Giacomo Rossini, Francesco Manti, Antonella Crispino, Caterina Riillo, Domenico Ciliberto et al. · 2023 · Frontiers in Oncology
  21. Liquid Biopsies for Colorectal Cancer and Advanced Adenoma Screening and Surveillance: What to Measure?
    Ellis L. Eikenboom, Saskia M. Wilting, Teoman Deger, Malgorzata Ilona Srebniak, Monique M. van Veghel–Plandsoen, Ruben Boers, Joachim Boers, Wilfred F. J. van IJcken, Joost H. Gribnau, Peggy N. Atmodimedjo et al. · 2023 · Cancers
  22. An Update on the Genetic Drivers of Corticotroph Tumorigenesis
    Laura Cristina Hernández-Ramírez, Luis Gustavo Perez‐Rivas, Marily Theodoropoulou, Márta Korbonits · 2024 · Experimental and Clinical Endocrinology & Diabetes
  23. Immunohistochemistry in screening for heritable colorectal cancer: what to do with an abnormal result
    Steven Ronald Paredes, Charles Chan, Matthew J. F. X. Rickard · 2019 · ANZ Journal of Surgery
  24. Patients with unexplained mismatch repair deficiency are interested in updated genetic testing
    Jessica Omark, Eduardo Vilar, Y. Nancy You, Leslie A. Dunnington, Sarah Jane Noblin, Blair Stevens, Maureen E. Mork · 2020 · Hereditary Cancer in Clinical Practice
  25. Complete Loss of EPCAM Immunoexpression Identifies EPCAM Deletion Carriers in MSH2-Negative Colorectal Neoplasia
    Míriam Cuatrecasas, Íñigo Gorostiaga, Cristina Riera, Esteban Saperas, Gemma Llort, Irmgard Costa, Xavier Matías‐Guiu, Cristina Carrato, Matilde Navarro, Marta Pineda et al. · 2020 · Cancers
  26. Population epigenetics, ecotoxicology and human diseases
    Eugene L. Patkin, Henry A Sofronov · 2012 · Ecological genetics
  27. The analysis of a large Danish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 11q24
    Laura Aviaja Rudkjøbing, Hans Eiberg, Hanne Birte Mikkelsen, Marie Louise Mølgaard Binderup, Marie Luise Bisgaard · 2015 · Familial Cancer
  28. A modified screening strategy for Lynch syndrome among MLH1-deficient CRCs: Analysis from consecutive Chinese patients in a single center
    Wenmiao Wang, Jianming Ying, Susheng Shi, Qiurong Ye, Shuangmei Zou, Dong Lin, Ning Lyu · 2021 · Translational Oncology
  29. A EPCAM Pathogenic Variant in Familial Lynch Syndrome-Associated Colon Cancer: Insights into Genetic Basis and Tumor Microenvironment Characteristics
    Sumeng Wang, Ke Zhang, Yifei Cheng, Lingxiang Liu, Mulong Du · 2025 · Phenomics
  30. Population frequency of Predicted pathogenic MisMatch Repair (MMR) gene variants in Lynch syndrome from bioinformatic analyses of the general population
    Yu Guan, Mary Huang, Finlay Macrae, Xiaoyu Yin, John‐Paul Plazzer, Judy Savige · 2025 · Scientific Reports
  31. Colorectal cancer in Lynch syndrome families: consequences of gene germline mutations and the gut microbiota
    Xuexin Wang, Zhijun Zheng, Dongliang Yu, Xiaojue Qiu, Ting Yang, Ruoran Li, Jing L. Liu, Xin Wang, Peng Jin, Jian-qiu Sheng et al. · 2025 · Orphanet Journal of Rare Diseases
  32. Genome-wide DNA methylation profiles of colorectal tumors in Lynch syndrome and familial adenomatous polyposis
    Satu Mäki‐Nevala, Anni Kauppinen, Alisa Petriina Olkinuora, Aleksi Laiho, Petri Törönen, Laura Renkonen‐Sinisalo, Anna Lepistö, Toni T. Seppälä, Jukka‐Pekka Mecklin, Païvi Peltomäki · 2025 · Clinical Epigenetics
  33. Optimizing risk‐reducing surgery and aspirin decision aids for Lynch syndrome carriers using the person‐based approach: A think‐aloud interview study
    Kelly Kohut, Kate Morton, Lesley Turner, Rebecca Foster, Elizabeth K. Bancroft, John Burn, Emma J. Crosbie, M. Dominguez-Valentin, M. Esplen, Helen Hanson et al. · 2025 · Journal of Genetic Counseling
  34. Genome-wide DNA methylation profile of leukocytes from melanoma patients with and without CDKN2A mutations
    Érica Sara Souza de Araújo, Fábio Albuquerque Marchi, Tatiane Cristina Rodrigues, Henrique Cursino Vieira, Hellen Kuasne, Maria Isabel Achatz, Luciana Facure Moredo, Bianca Costa Soares de Sá, João Pedreira Duprat Neto, Helena Brentani et al. · 2014 · Experimental and Molecular Pathology
  35. Molecular Approach to Colorectal Carcinoma
    Cameron M. Beech, Jaclyn Frances Hechtman · 2021 · Surgical pathology clinics
  36. Novel Pathogenic Variants in Hereditary Cancer Syndromes in a Highly Heterogeneous Cohort of Patients: Insights from Multigene Analysis
    Airat I. Bilyalov, Данишевич Анастасия Михайловна, Sergey Nikolaev, Nikita Vorobyov, Ivan S. Abramov, Ekaterina Pismennaya, Svetlana Terehova, Yuliya Kosilova, Anastasiia Primak, У. С. Станоевич et al. · 2023 · Cancers
  37. Characterization of Screening Strategies for Lynch Syndrome in Latin America
    Anthony Vladimir Campos Segura, Karin Álvarez, Alexis German Murillo Carrasco, Benedito Mauro Rossi, Mábel Bohórquez, Florencia Spirandelli, Claudio Benavides, Aina Balto, Adriana Della Valle, Luisina Ines Bruno et al. · 2025 · Clinical Gastroenterology and Hepatology
  38. Candidate predisposing germline copy number variants in early onset colorectal cancer patients
    Alejandro Brea‐Fernández, Ceres Fernández–Rozadilla, Míriam Álvarez-Barona, Daniel Azuara, M. M. Ginesta, Juan Clofent, Luisa de Castro, D. Gonzalez, Montserrat G. Andreu, Xavier Bessa et al. · 2016 · Clinical & Translational Oncology
  39. Aberrant DNA Methylation
    Constance Regina Baer, C. Plass · 2014 · Elsevier eBooks
  40. Genome-wide analysis of constitutional DNA methylation in familial melanoma
    Catarina Salgado, Nelleke A. Gruis, Bastiaan T. Heijmans, Jan Oosting, Remco van Doorn · 2020 · Clinical Epigenetics
  41. Genomic landscape of colorectal carcinoma in sub-Saharan Africa
    Alessandro Pietro Aldera, Komala Pillay, Barbara Robertson, Adam Boutall, Raj Ramesar · 2022 · Journal of Clinical Pathology
  42. Molecular Testing in Colorectal Cancer
    Jessica S. Thomas, Chanjuan Shi · 2016 · Elsevier eBooks
  43. Therapy Implications of DNA Mismatch Repair Deficiency, Microsatellite Instability, and Tumor Mutation Burden
    Maryam Shirazi, Antonia R. Sepulveda · 2018 · Advances in Molecular Pathology
  44. A Hereditable Mutation of MSH2 Gene Associated with Lynch Syndrome in a Five Generation Chinese Family
    Weihua Shao, Chengyu Wang, Lei‐Yun Wang, Fan Xiao, Desheng Xiao, Hao Yang, Xueying Long, Le Zhang, Heng-Gui Luo, Ji‐Ye Yin et al. · 2020 · Cancer Management and Research
  45. Cysteine-Poor Region-Specific EpCAM Monoclonal Antibody Recognizing Native Tumor Cells with High Sensitivity
    Masashi Takao, Yutaka Nagai, Tokiji Torii · 2013 · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
  46. Design and validation of an oligonucleotide microarray for the detection of genomic rearrangements associated with common hereditary cancer syndromes
    Debora Mancini‐DiNardo, Thaddeus Judkins, Nick Woolstenhulme, Collin Burton, Jeremy Schoenberger, Matthew B. Ryder, Adam Murray, Natalia Gutin, Aaron P. Theisen, Jayson Holladay et al. · 2014 · Journal of Experimental & Clinical Cancer Research
  47. Risk profiling: Familial colorectal cancer
    Aung Ko Win, Driss Ait Ouakrim, Mark A. Jenkins · 2020 · Figshare
  48. Genetic Factors
    Kasmintan A. Schrader, Ravi Sharaf, Shaheen Riadh Alanee, Kenneth Offit · 2014 · Elsevier eBooks
  49. Screening patients at high risk for pancreatic cancer—Is it time for a paradigm shift?
    Winifred M. Lo, Mackenzie C. Morris, Syed Ameen Ahmad, Sameer H. Patel · 2019 · Journal of Surgical Oncology
  50. Lynch Syndrome
    Henry T. Lynch · 2014 · Springer eBooks
  51. Approaches for Lynch syndrome screening and characteristics of subtypes with mismatch repair deficiency in patients with colorectal carcinoma
    Feng Xu, Qianlan Yao, Yuyin Xu, Jing Zhang, Liqin Jia, Qian Wang, Xu Cai, Ye Xu, Fangqi Liu, Dan Huang et al. · 2024 · International Journal of Cancer
  52. Constitutional Epimutations: From Rare Events Toward Major Cancer Risk Factors?
    Per Eystein Lønning, Oleksii Nikolaienko, Stian Knappskog · 2025 · JCO Precision Oncology
  53. A human somatic cell culture system for modelling gene silencing by transcriptional interference
    Theresa Kühnel, Helena Heinz, Nadja Utz, Tanja Božić, Bernhard Horsthemke, Laura Steenpaß · 2020 · Heliyon
  54. Lynch Syndrome
    Elena M. Stoffel, Matthew B.B. Yurgelun, Clement Richard Boland · 2018 · Springer eBooks
  55. Risk of Metachronous Colorectal Cancer in Lynch Syndrome: Who Needs an Extended Resection?
    Johannes Doerner · 2022 · Surgeries
  56. Pediatric Rectal Adenocarcinoma With Mismatch Repair Deficiency Responds to Immunotherapy
    Naveen Qureshi, Trevor L. Hoffman, Kristiyana Kaneva, Sina Zomorrodian, Jason V. Scapa, Megan Philippa Hitchins, Noah C. Federman · 2023 · JCO Precision Oncology
  57. MGMT epimutations and risk of incident cancer of the colon, glioblastoma multiforme, and diffuse large B cell lymphomas
    Oleksii Nikolaienko, Garnet L. Anderson, Rowan T. Chlebowski, Su Yon Jung, Holly Ruth Harris, Stian Knappskog, Per Eystein Lønning · 2025 · Clinical Epigenetics
  58. Defectos de la metilación del ADN en el cáncer colorrectal esporádico y hereditario
    Rosa M. Xicola, Xavier Llor · 2012 · Gastroenterología y Hepatología
  59. Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity
    M. P. Farrell, David J. Hughes, Mark Drost, Andrew J. Wallace, Robert Cummins, Tracy A. Fletcher, Marie Meany, Elaine Williamson Kay, Niels de Wind, Derek Gerard Power et al. · 2013 · Familial Cancer
  60. A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer
    Zhigang Yao, Beibei Lv, Haiyan Jing, Wenjing Su, Jiamei Li, Hui Fan, Miaoqing Zhao, Yejun Qin, Xichao Sun · 2021 · Journal of Cancer Research and Therapeutics
  61. Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer
    Rachel Hodan, Linda Rodgers, Sanjeevani Arora, Mev Dominguez–Valentin, Priyanka Kanth, Bryson W. Katona, Kathryn A. Mraz, Maegan E. Roberts, Eduardo Vilar, Cynthia Soto-Azghani et al. · 2022 · Journal of Genetic Counseling
  62. Large Cancer Pedigree Involving Multiple Cancer Genes including Likely Digenic MSH2 and MSH6 Lynch Syndrome (LS) and an Instance of Recombinational Rescue from LS
    Ingrid P. Vogelaar, Stephanie Greer, Fan Wang, Gi Won Shin, Billy T. Lau, Yajing Hu, Sigurdís Haraldsdóttir, Rocio Alvarez, Dennis J. Hazelett, Peter Nguyen et al. · 2022 · Cancers
  63. Pathologic Evaluation of Therapeutic Biomarkers in Colorectal Adenocarcinoma
    Esther Baranov, Jonathan Andrew Nowak · 2023 · Surgical pathology clinics
  64. Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers
    Katarína Závodná, Tomas Krivulcik, Maria Gerykova Bujalkova, Tomáš Slamka, David Martinicky, Denisa Ilenčíková, Zdena Bartošová · 2009 · BMC Cancer
  65. Molecular Basis of Diseases of the Gastrointestinal Tract
    Antonia R. Sepulveda, Dara L. Aisner · 2009 · Elsevier eBooks
  66. An investigation of the potential for epigenetic inactivation by transcription read-through in a sporadic colorectal cancer
    Sameer Srivastava, Anne Kathrin Ludwig, Jason W.H. Wong, Luke B. Hesson · 2016 · Gene
  67. Hereditary Colorectal Cancer
    Sonia S. Kupfer, Nathan A. Ellis · 2016 · Springer eBooks
  68. Characterization of Molecular Alterations in an Unusual Case of Lynch Syndrome–Associated Adrenocortical Carcinoma
    Megan Parilla, Larissa V. Furtado, Sabah Kadri, Jeremy P. Segal, Tatjana Antic · 2017 · AJSP Review and Reports
  69. How Helpful Is Age at Colorectal Cancer Onset in Finding Hereditary Nonpolyposis Colorectal Cancer?
    Patrick M. Lynch · 2011 · Clinical Gastroenterology and Hepatology
  70. Unraveling noncoding DNA variants and epimutations: a paradigm shift in hereditary cancer research
    Maria Baz Ibrahim, James M. Flanagan, Tony Ibrahim, Étienne Rouleau · 2024 · Future Oncology
  71. Pathological complete response following addition of durvalumab to gemcitabine and cisplatin therapy for intrahepatic cholangiocarcinoma with Lynch syndrome-associated mismatch repair deficiency
    Koshiro Fukuda, Akiyoshi Kasuga, Yasuyuki Shigematsu, Kenichiro Kato, Hiromichi Ito, Arisa Ueki, Takeshi Okamoto, Masato Ozaka, Yu Takahashi, Naoki Sasahira · 2025 · Clinical Journal of Gastroenterology
  72. Integrated tumor and germline profiling of lynch syndrome in a North Indian cohort
    Himanshi Diwan, Anurag Mehta, Saudamini Sharma, Sakshi Mattoo, Shalini Agnihotri · 2026 · Frontiers in Oncology
  73. Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene
    Wybrich R Cnossen, Jake S.F. Maurits, Jody Salomon, René H. M. te Morsche, Esmé Waanders, Joost P.H. Drenth · 2015 · Journal of Clinical Laboratory Analysis
  74. Diagnosis and Management of Hereditary Pancreatic Cancer
    Jeremy L. Humphris, Andrew Victor Biankin · 2016 · Recent results in cancer research/Recent Results in Cancer Research
  75. DNA Methylation and Its Effect on Various Cancers: An Overview
    Sabitha Vadakedath, Venkataramana Kandi · 2016 · Journal of Molecular Biomarkers & Diagnosis
  76. DNA Methylation and Epigenetic Biomarkers in Cancer
    Michel Neidhart · 2015 · Elsevier eBooks
  77. Assessing the adherence to guidelines in Lynch syndrome patients: a pilot study
    Li‐Han Goh, Allan D. Spigelman · 2020 · ANZ Journal of Surgery
  78. Feasibility of Utilizing PREMM Score for Lynch Syndrome Identification in an Urban, Minority Patient Population
    Brigid Adviento, Michael Conner, Alexander M. Sarkisian, Nicolette Walano, Hans C. Andersson, Jordan J. Karlitz · 2021 · Journal of Primary Care & Community Health
  79. Lynch syndrome: influence of additional susceptibility variants on cancer risk
    Roseline Vibert, Jasmine Hasnaoui, Alexandre Perrier, Alexandra Lefebvre, Chrystelle Colas, Marion Dhooge, Noémie Basset, Albain Chansavang, Camille Desseignés, Alex Duval et al. · 2023 · European Journal of Human Genetics
  80. Investigating somatic variants and pathways in mismatch repair-deficient (dMMR) colorectal carcinoma in South Africa
    Alessandro Pietro Aldera, Jana van der Westhuizen, Wan-Jung Tsai, May J. Krause, Safiye Yildiz, Komala Pillay, Adam Boutall, Raj Ramesar · 2024 · Journal of Clinical Pathology
  81. Hereditary Gynecologic Cancer Predisposition Syndromes
    Allison L. Goetsch, Dana Kimelman, Teresa K. Woodruff · 2017 · Springer eBooks
  82. The Molecular Basis of Lynch-like Syndrome
    Gardenia Vargas‐Parra, Matilde Navarro, Marta Pineda, Gabriel Capellá · 2018 · Springer eBooks
  83. Scrutinizing the Epigenetics Revolution
    Maurizio Meloni, Giuseppe Testa · 2017 · Palgrave Macmillan UK eBooks
  84. Historical Aspects of Lynch Syndrome
    Henry T. Lynch, Megan Philippa Hitchins, Trudy G. Shaw, Jane F. Lynch, Hemant K. Roy · 2010 · Springer eBooks
  85. Brain Tumors and the Lynch Syndrome
    Païvi Peltomäki, Annette Gylling · 2011 · InTech eBooks
  86. Genetic Counseling for Cancer: Technology Promises Better Screening for Hereditary Cancer Patients
    Kristin Baker Niendorf, Brittany C. Thomas · 2013 · Current Genetic Medicine Reports
  87. An MSH6 germline pathogenic variant p.Gly162Ter associated with Lynch syndrome
    Olga A. Vostrukhina, E. D. Mirlina, Хмелькова Дарья Николаевна, G. M. Butrovich, A. D. Shakhmatova, Yury Kil, Yliya L. Polyatskin, Anna Sergeevna Artemyeva, Alexey V. Gulyaev, Valery N. Verbenko · 2022 · Human Genome Variation
  88. Favoritism in DNA Methylation
    Megan Philippa Hitchins, Robyn Lynne Ward · 2009 · Cancer Prevention Research
  89. Preventive dendritic cell vaccination induced TGF-βRII frameshift neoantigen-specific T-cells are linked to long-term disease-free survival in Lynch Syndrome patients
    I. Jolanda M. de Vries, Asima Abidi, Harm Westdorp, Mark A.J. Gorris, Steve Boudewijns, Florian Wimmers, Tanya M. Bisseling, Maria van Vugt-van Pinxteren, Fokko M. Nagengast, Anna de Goede et al. · 2025 · Research Square
  90. Evaluation of a combined model of Polygenic Risk Score and mismatch repair genes in the association of colorectal cancer for Norwegian cohort
    Bayram Cevdet Akdeniz, Andrew H. Morris, Pål Møller, Ole A. Andreassen, Eivind J. Hovig, Mev Dominguez–Valentin · 2024 · Tumori Journal
  91. An Integrated Clinical, Germline, Somatic, and In Silico Approach to Assess a Novel PMS2 Gene Variant Identified in Two Unrelated Lynch Syndrome Families
    Candida Fasano, Antonia Lucia Buonadonna, Giovanna Forte, Martina Lepore Signorile, Valentina Grossi, Katia De Marco, Paola Sanese, Andrea Manghisi, Nicoletta Maria Tutino, Raffaele Armentano et al. · 2025 · Cancers
  92. Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancer
    Jussi Nikkola, Lauri Ryyppö, Juuso Vuorinen, Lauri Moilanen, Maarit Ahtiainen, Kirsi Pylvänäinen, Hanna Selin, Tuomo Virtanen, Matti Nykter, Thea Veitonmäki et al. · 2025 · Cell Reports
  93. Carcinogenesis trajectories
    Rui Wang, Zhaopeng Yan · 2025 · Frontiers in Cell and Developmental Biology
  94. Estimating the prevalence of germline mutations in DNA mismatch repair genes among patients with upper tract urothelial carcinoma: a systematic review and meta-analysis
    Joseph Moryousef, Braden Millan, Piotr Zareba · 2026 · Urologic Oncology Seminars and Original Investigations
  95. Cancer risks in the Lynch syndromes
    William David Foulkes, Aysel Ahadova · 2026 · JNCI Journal of the National Cancer Institute
  96. Near-perfect genome sequencing in medical genetics
    Quentin Sabbagh, Christian Gilissen, Helger G. Yntema, Lisenka E.L.M. Vissers, Alexander Hoischen · 2026 · Nature Genetics
  97. Genetics of Young Onset Colorectal Cancer
    Esha Baichoo Lisa A Boardman · 2014 · Journal of Bone Marrow Research
  98. Synchronous cancers of the colon and rectum
    D. N. Chirilă, N A Turdeanu, Nicolae Augustin Constantea, Tudor Radu Pop, Sorin D. Porumbel, Cătălina Ileana Bungărdean, Bogdan Vasile Micu, Dan Damian Axente, Sorin Crişan, Constantin Ciuce · 2012
  99. Unexplained mismatch repair deficiency: Case closed
    Ellis L. Eikenboom, Sarah Moen, Lotte van Leeuwen, Willemina R.R. Geurts-Giele, Carli M.J. Tops, Tjakko J. van Ham, Winand N.M. Dinjens, Hendrikus Jan Dubbink, Manon C.W. Spaander, Anja Wagner · 2022 · Human Genetics and Genomics Advances
  100. What is precision medicine in oncology?
    Mariamena Arbitrio, Alessia Cordua, Valentina Uppolo, Maria D’Apolito, Daniele Caracciolo, Nicoletta Staropoli, Onofrio Cuomo, Lucia Fiorillo, Pierfrancesco Tassone, Maria Teresa Di Martino et al. · 2023 · Elsevier eBooks